Cerebral Perfusion Pressure Using Precedex and Other Sedatives

Completed · Phase 3

Conditions studied: Endotracheal Intubation, Continuous IV Sedation, ICP Monitoring

In brief

The purpose of this study is to examine the effects of using dexmedetomidine (Precedex) in addition to the current standard-of-care for sedation.

Key facts

Study ID

NCT01169467

Run by

Duke University

People needed

89

Starts

2009-10-01

Expected to finish

2013-11-01

Last updated by the study team

2015-11-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Admitted to Duke University Neuro Critical Care Unit (NCCU)
• Adult (18 years of age or older)
• Expected Mechanical Ventilation for >48 hours with sedation
• Intraventricular catheter in situ

You may not qualify if…

• Hypersensitivity to study drugs
• Prisoners
• Moribund state or death expected within 24 hours
• Surgery planned within 24 hours of subject enrollment
• Receiving study drug, Precedex, prior to entering study

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.